Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Shares Outstanding (Weighted Average) (2023 - 2025)

Rallybio's Shares Outstanding (Weighted Average) history spans 3 years, with the latest figure at $44.9 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 0.67% year-over-year to $44.9 million; the TTM value through Sep 2025 reached $44.9 million, up 0.67%, while the annual FY2024 figure was $43.5 million, 7.66% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $44.9 million at Rallybio, roughly flat from $44.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $44.9 million in Q3 2025 and bottomed at $40.2 million in Q1 2023.
  • The 3-year median for Shares Outstanding (Weighted Average) is $43.5 million (2024), against an average of $42.6 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) rose 10.02% in 2024 before it grew 0.67% in 2025.
  • A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $40.4 million in 2023, then rose by 7.66% to $43.5 million in 2024, then increased by 3.09% to $44.9 million in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Shares Outstanding (Weighted Average) are $44.9 million (Q3 2025), $44.8 million (Q2 2025), and $44.8 million (Q1 2025).